SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-034671
Filing Date
2024-03-14
Accepted
2024-03-14 20:52:35
Documents
1
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248935-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm248935-2_4seq1.xml 4 9259
  Complete submission text file 0001104659-24-034671.txt   10670
Mailing Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address
HENNEMAN JOHN B III (Reporting) CIK: 0001187572 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 24752208

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)